Interventions for the treatment of obstructive sleep apnea in adults recommendations

Obstructive sleep apnea (OSA) is characterized by a narrowing and collapse of the upper airway during sleep. The prevalence of OSA is reported to be 15% in males and 5% in females. The major symptoms include snoring, unrefreshing sleep, excessive daytime sleepiness (EDS), lack of concentration, impa...

Full description

Bibliographic Details
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa, Ontario Canadian Agency for Drugs and Technologies in Health 2017, March 2017
Series:CADTH optimal use report
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02274nam a2200289 u 4500
001 EB001839434
003 EBX01000000000000001003423
005 00000000000000.0
007 tu|||||||||||||||||||||
008 180702 r ||| eng
245 0 0 |a Interventions for the treatment of obstructive sleep apnea in adults  |h Elektronische Ressource  |b recommendations 
260 |a Ottawa, Ontario  |b Canadian Agency for Drugs and Technologies in Health  |c 2017, March 2017 
300 |a 1 PDF file (22 pages) 
505 0 |a Includes bibliographical references 
653 |a Orthodontic Appliances 
653 |a Continuous Positive Airway Pressure 
653 |a Otorhinolaryngologic Surgical Procedures 
653 |a Sleep Apnea, Obstructive / therapy 
653 |a Treatment Outcome 
653 |a Health Behavior 
710 2 |a Canadian Agency for Drugs and Technologies in Health 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a CADTH optimal use report 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK487362  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610 
520 |a Obstructive sleep apnea (OSA) is characterized by a narrowing and collapse of the upper airway during sleep. The prevalence of OSA is reported to be 15% in males and 5% in females. The major symptoms include snoring, unrefreshing sleep, excessive daytime sleepiness (EDS), lack of concentration, impaired memory, and lower quality of life. Aging, the male sex, and obesity are the main risk factors for OSA. Untreated OSA is associated with motor vehicle accidents, cardiovascular disease, stroke, hypertension, diabetes, cognitive dysfunction, and all-cause mortality. Given the range of clinical presentation, symptoms, and severity, recommending the most appropriate treatment for OSA patients can be challenging. To facilitate decision-making, CADTH conducted a health technology assessment (HTA) on the clinical effectiveness and costeffectiveness of interventions for the treatment of OSA in adults. Patient perspectives and experiences, ethical and implementation issues, and environmental factors related to therapy selection for OSA in adults were also considered in an evaluation of the appropriate use of OSA interventions